Ucsd Mdcl Ct-Infusion-Outptnt San Diego, CA - 92131

Ucsd Mdcl Ct-Infusion-Outptnt is categorized under Blood Related Health Services in San Diego, CA .

Ucsd Mdcl Ct-Infusion-Outptnt was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 621991 by the NAICS.

If you are seeking more information, feel free to contact Cecilia A Gutierrez at the company’s branch by writing to 9909 Mira Mesa Boulevard # 200, San Diego, California CA 92131 or by phoning (858) 657-7750. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Ucsd Mdcl Ct-Infusion-Outptnt
Contact Person: Cecilia A Gutierrez
Address: 9909 Mira Mesa Boulevard # 200, San Diego, California 92131
Phone Number: (858) 657-7750
Website Address: health.ucsd.edu
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Blood Related Health Services
SIC Code: 8099
NAICS Code: 621991
Share This Business:

Ucsd Mdcl Ct-Infusion-Outptnt was started in 0 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 621991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Cecilia A Gutierrez for inquiries that concern Ucsd Mdcl Ct-Infusion-Outptnt by calling the company number (858) 657-7750, as your correspondence is most welcome. Additionally, the physical location of the branch of Ucsd Mdcl Ct-Infusion-Outptnt can be found at the coordinates 32.916564,-117.112992 as well as the street address 9909 Mira Mesa Boulevard # 200 in San Diego, California 92131.

For its online presence, you may visit Ucsd Mdcl Ct-Infusion-Outptnt’s website at health.ucsd.edu and engage with its social media outlets through on Twitter and on Facebook.